Physician profile
Ashesh Devendra Desai
NPI 1649308966
$14,253.58
in general payments reported to CMS, 2019-2025
47 companies · $2,956 in 2025
The $2,956 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,886 · 2020: $1,274 · 2021: $1,641 · 2022: $1,960 · 2023: $2,305 · 2024: $2,232 · 2025: $2,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,309 · Consulting Fee: $150 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,309.19 |
| Consulting Fee | $150.00 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,423.47 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $2,633.32 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Mylan Specialty L.P. | $1,016.14 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,002.69 | 2019-2025 | Ofev |
| Jazz Pharmaceuticals INC. | $719.46 | 2019-2025 | |
| Amgen INC. | $546.52 | 2021-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $426.80 | 2019-2025 | Dupixent |
| Genzyme Corporation | $414.33 | 2019-2025 | |
| Harmony Biosciences LLC | $334.62 | 2022-2025 | Wakix |
| Verona Pharma, INC. | $322.90 | 2025 | Ohtuvayre |
| Shionogi INC | $265.14 | 2021-2024 | Fetroja |
| Electromed, INC. | $261.24 | 2019-2024 | Smartvest |
| Avadel Cns Pharmaceuticals, LLC | $249.23 | 2023-2025 | Lumryz |
| Axsome Therapeutics, INC. | $241.82 | 2023-2025 | Sunosi |
| Sunovion Pharmaceuticals INC. | $224.10 | 2019-2021 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $195.83 | 2023-2025 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Genentech USA, INC. | $192.77 | 2019-2023 | Xolair |
| Insmed, INC. | $190.73 | 2023-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $186.68 | 2022-2025 | Aralast, Glassia, Hyqvia |
| Viatris Specialty LLC | $182.68 | 2025 | Yupelri |
| Philips North America LLC | $142.15 | 2019-2025 | Vest Therapy Und, Sleepundivided |
| Grifols USA, LLC | $96.96 | 2021-2025 | Xembify, Prolastin-C Liquid |
| Optinose US, INC. | $74.59 | 2021-2022 | |
| United Therapeutics Corporation | $68.63 | 2021-2024 | Tyvaso |
| Gilead Sciences, INC. | $68.28 | 2019-2024 | Veklury |
| Inogen, INC. | $62.43 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Circassia INC. | $61.22 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $57.48 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $53.93 | 2020-2021 | |
| Resmed Corp | $50.41 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $47.85 | 2023-2024 | Nuzyra |
| Janssen Pharmaceuticals, INC | $47.79 | 2021-2022 | |
| Ethicon INC. | $46.55 | 2024-2025 | Monarch Platform |
| Actelion Pharmaceuticals US, INC. | $44.49 | 2019-2023 | Uptravi, Opsumit |
| Zoll Respicardia, INC. | $40.85 | 2023 | Remede System |
| Merck Sharp & Dohme LLC | $30.83 | 2019-2021 | |
| Melinta Therapeutics, LLC | $28.12 | 2021 | |
| Lilly USA, LLC | $25.17 | 2025 | Zepbound |
| Edwards Lifesciences Corporation | $22.90 | 2023 | Sapien 3 Ultra Resilia |
| Ars Pharmaceuticals Operations, INC. | $22.89 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $22.30 | 2022 | |
| Biomerieux INC | $20.63 | 2019 | |
| Tactile Systems Technology INC | $19.55 | 2024 | Flexitouch Plus, Entre Plus |
| Masimo Corporation | $19.39 | 2022 | |
| Baxter Healthcare | $19.36 | 2023 | Hillrom - Life 2000 Ventilation System |
| Allergan, INC. | $15.09 | 2019 | |
| Hikma Pharmaceuticals USA | $13.27 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,093.06 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashesh Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.